Expert Review of Pharmacoeconomics & Outcomes Research

• Pneumococcal Conjugate Vaccine: Review of Cost-Effectiveness Studies In mid-2000, PCV was reported to be the single most expensive vaccine ever introduced. How can we measure whether the high cost is justified?
  Expert Review of Pharmacoeconomics & Outcomes Research, August 01, 2008
• Specific Patient-Reported Outcome Measures for Parkinsons Disease Read this clinical update to learn how patient-reported outcomes can contribute to the research of Parkinsons.
  Expert Review of Pharmacoeconomics & Outcomes Research, August 01, 2008
• Gefitinib: A Consideration of Cost Higher quality of life scores from recent trials suggest that gefitinib may be a treatment option with greater utility for patients with non-small-cell lung cancer.
  Expert Review of Pharmacoeconomics & Outcomes Research, June 01, 2008
• The Cost-Effectiveness of Treatments for Male Infertility Male-specific treatments play a larger role than ever in the care of the infertile couple.
  Expert Review of Pharmacoeconomics & Outcomes Research, April 01, 2008
• Are Medicare Plans Complying With CMS Regulation? Formulary exclusions and restrictions may be violating federal guidelines and harming patients.
  Expert Review of Pharmacoeconomics & Outcomes Research, April 01, 2008
• Weekend Hospitalization and Mortality: A Critical Review What is the real relationship between patient deaths and weekend hospital stays?
  Expert Review of Pharmacoeconomics & Outcomes Research, February 01, 2008
• Can Inhaled Insulin Be Used for the Treatment of Diabetes Mellitus? Without drawing lessons from the Exubera tragedy, any future introduction of inhaled insulin products will risk the same fate.
  Expert Review of Pharmacoeconomics & Outcomes Research, February 01, 2008
• Escitalopram in the Treatment of Major Depressive and Anxiety Disorders Although it is more expensive than generic alternatives, escitalopram may save money overall by lowering indirect costs such as lost productivity.
  Expert Review of Pharmacoeconomics & Outcomes Research, December 01, 2007
• Effects of Polycystic Ovary Syndrome on Health-related Quality of Life The negative impact of PCOS does not necessarily correlate with disease severity, but what factors do influence these patients' quality of life?
  Expert Review of Pharmacoeconomics & Outcomes Research, December 01, 2007
• Quality of Life and Economic Burden in Patients With Restless Legs Syndrome When evaluating the efficacy of new medications for RLS, quality of life factors should be considered along with clinical factors.
  Expert Review of Pharmacoeconomics & Outcomes Research, October 01, 2007
• Child Health Questionnaire in a Dutch Adolescent Population The aims of this study were to evaluate structure, reliability and validity of the Dutch version of the CHQ-CF87 among adolescents in the general Dutch population.
  Expert Review of Pharmacoeconomics & Outcomes Research, August 01, 2007